Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0000919574-13-007044
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-12-30 18:26:10
Reporting Period:
2013-12-26
Filing Date:
2013-12-30
Accepted Time:
2013-12-30 18:26:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
876343 Biotime Inc BTX Biological Products, (No Disgnostic Substances) (2836) 943127919
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1278386 Broadwood Partners Lp C/o Broadwood Capital Inc.
724 Fifth Avenue, 9Th Floor
New York NY 10019
No No Yes No
1278387 Broadwood Capital Inc 724 Fifth Avenue, 9Th Floor
New York NY 10019
No No Yes No
1278388 C Neal Bradsher C/o Broadwood Capital Inc.
724 Fifth Avenue, 9Th Floor
New York NY 10019
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-12-26 69,042 $3.53 9,091,262 No 4 P Direct
Common Stock Acquisiton 2013-12-26 0 $0.00 9,091,262 No 4 P Indirect Footnote
Common Stock Acquisiton 2013-12-27 56,000 $3.53 9,147,262 No 4 P Direct
Common Stock Acquisiton 2013-12-27 0 $0.00 9,147,262 No 4 P Indirect Footnote
Common Stock Acquisiton 2013-12-30 175,000 $3.49 9,322,262 No 4 P Direct
Common Stock Acquisiton 2013-12-30 0 $0.00 9,322,262 No 4 P Indirect Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Indirect Footnote
No 4 P Direct
No 4 P Indirect Footnote
No 4 P Direct
No 4 P Indirect Footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 42,908 Direct
Footnotes
  1. This constitutes the weighted average purchase price. The prices range from $3.49 to $3.55. The Reporting Persons will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
  2. These securities are owned by Broadwood Partners, L.P., which is a Reporting Person.
  3. The reported securities are directly owned by Broadwood Partners, L.P. and may be deemed beneficially owned by Broadwood Capital, Inc. as General Partner of Broadwood Partners, L.P. and Neal C. Bradsher as President of Broadwood Capital, Inc. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
  4. This constitutes the weighted average purchase price. The prices range from $3.50 to $3.57. The Reporting Persons will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
  5. This constitutes the weighted average purchase price. The prices range from $3.46 to $3.54. The Reporting Persons will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
  6. These securities are owned by Neal C. Bradsher, who is a Reporting Person.